Skip to main content
. Author manuscript; available in PMC: 2016 Jul 7.
Published in final edited form as: Nature. 2016 Jan 13;529(7586):351–357. doi: 10.1038/nature16478

Extended Data Figure 9. Pathway enrichment results for genes recurrently aberrant in the primary tumour or recurrent tumour cohorts.

Extended Data Figure 9

Pathway enrichment analysis of gene lists derived from the integrative analysis of CNVs (gain or loss of 2 or more copies), SNVs, indels, and structural variants specific to the primary or recurrent tumours of each patient was performed using g:Cocoa.